Please assess the completion status of the following clinical trial:

Trial Title: Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Population:~All patients already scheduled for biopsy because of a raised Prostate-Specific Antigen (PSA) and/ or abnormal Digital Rectal Examination (DRE) in the Academic Medical Centre (AMC), excluding patients who do meet the exclusion criteria.~Inclusion criteria:~* age ≥ 18 years~* signed informed consent~Exclusion criteria:~* Has documented acute prostatitis or urinary tract infections.~* History of any clinically unstable cardiac condition including class III/IV cardiac failure or right-to-left shunts.~* Has had severe cardiac rhythm disorders within the last 7 days.~* Has severe pulmonary hypertension (pulmonary artery pressure \>90 mmHg) or uncontrolled systemic hypertension or respiratory distress syndrome~* Has received a biopsy procedure within 30 days before admission into this study~* Has any medical condition or other circumstances which would significantly decrease the chances of obtaining reliable data, achieving study objectives, or completing the study.~* Is incapable of understanding the language in which the information for the patient is given.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SonoVue (Type: OTHER): Ultrasound Contrast Agent

Based on this trial design, predict the completion outcome and termination type (if applicable).